NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
05 janv. 2024 08h30 HE
|
NurExone Biologic Inc
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration
29 nov. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone Biologic expands its portfolio of products to address spinal cord injuries & neuron regeneration in CNS indications
NurExone Reports Third Quarter 2023 Financial Results and Provides Corporate Update
24 nov. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone released a corporate update and reported financial results for the quarter ended September 30, 2023.
NurExone Biologic Receives FDA Orphan-Drug Designation, Accelerating Development of ExoPTEN therapy for Acute Spinal Cord Injury Treatment
30 oct. 2023 09h20 HE
|
NurExone Biologic Inc
NurExone Biologic Receive FDA Orphan-Drug Designation to its ExoPTEN Therapy for Acute Spinal Cord Injury Treatment
NurExone Secures Eureka Grant for Collaborative Partnership to Expand to Chronic Spinal Cord Injury Therapy
11 oct. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone has been awarded a grant by the Israel Innovation Authority (“IIA”) as part of the Israel-Canada bilateral Eureka program
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
05 oct. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone Biologic will present at the EVs Forum in Cambridge presents advances in exosome therapy for spinal cord injuries, highlighting ExoPTEN potential
Global Acellular Therapy Market Size Was Valued at $8.451 Billion in 2022 and Is Projected to Surpass Around $32.61 Billion Mark by 2030, Growing at a CAGR of 16.21%
16 mars 2023 07h02 HE
|
Zion Market Research
Washington, DC, March 16, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Acellular Therapy Market By Disease (Parkinson’s, Alzeihmer’s, Chronic Wounds,...
The exosome therapeutics market is projected to grow at an annualized rate of 41%, claims Roots Analysis
13 déc. 2022 09h00 HE
|
Roots Analysis
London, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Exosome Therapeutics Market, 2022-2040” report to its list of offerings. With the advancements in...